BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17578480)

  • 1. Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.
    Bonovas S; Filioussi K; Tsantes A; Sitaras NM
    Br J Clin Pharmacol; 2007 Sep; 64(3):255-62. PubMed ID: 17578480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.
    Yi X; Jia W; Jin Y; Zhen S
    PLoS One; 2014; 9(1):e87019. PubMed ID: 24498014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies.
    Bonovas S; Filioussi K; Sitaras NM
    Am J Gastroenterol; 2008 Oct; 103(10):2646-51. PubMed ID: 18684187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
    Bonovas S; Filioussi K; Sitaras NM
    Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
    Lytras T; Nikolopoulos G; Bonovas S
    World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and the risk of lung cancer: a meta-analysis.
    Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
    PLoS One; 2013; 8(2):e57349. PubMed ID: 23468972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
    Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials.
    Bonovas S; Nikolopoulos G; Filioussi K; Peponi E; Bagos P; Sitaras NM
    Eur J Epidemiol; 2010; 25(1):29-35. PubMed ID: 19844794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
    Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
    Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.